Ying G. Li

1.5k total citations
21 papers, 1.2k citations indexed

About

Ying G. Li is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, Ying G. Li has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 7 papers in Pharmacology. Recurrent topics in Ying G. Li's work include Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Lipoproteins and Cardiovascular Health (11 papers) and Inflammatory mediators and NSAID effects (6 papers). Ying G. Li is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Lipoproteins and Cardiovascular Health (11 papers) and Inflammatory mediators and NSAID effects (6 papers). Ying G. Li collaborates with scholars based in United States, United Kingdom and Italy. Ying G. Li's co-authors include David S. Small, Kenneth J. Winters, Christopher D. Payne, Nagy A. Farid, Daniel E. Salazar, John T. Brandt, Joseph A. Jakubowski, Govinda Weerakkody, C. Steven Ernest and Lan Ni and has published in prestigious journals such as Circulation, Diabetes Care and Thrombosis and Haemostasis.

In The Last Decade

Ying G. Li

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ying G. Li United States	17	906	448	370	240	226	21	1.2k
Govinda Weerakkody United States	6	903 1.0×	402 0.9×	265 0.7×	250 1.0×	222 1.0×	7	1.1k
Bhaloo Desai United States	16	1.4k 1.5×	688 1.5×	244 0.7×	237 1.0×	411 1.8×	35	1.5k
Nicoline J. Breet Netherlands	18	1.7k 1.9×	831 1.9×	283 0.8×	234 1.0×	536 2.4×	28	1.8k
Bonnie L. Hiatt United States	6	1.3k 1.4×	687 1.5×	164 0.4×	185 0.8×	382 1.7×	9	1.4k
Guenter Christ Austria	5	476 0.5×	221 0.5×	111 0.3×	107 0.4×	81 0.4×	7	585
C. M. Hackeng Netherlands	15	702 0.8×	352 0.8×	155 0.4×	136 0.6×	199 0.9×	28	876
N. von Beckerath Germany	7	429 0.5×	221 0.5×	148 0.4×	123 0.5×	93 0.4×	8	541
Andrew Darlington United States	13	610 0.7×	246 0.5×	126 0.3×	123 0.5×	136 0.6×	24	702
Chantal Pharand Canada	15	831 0.9×	345 0.8×	119 0.3×	201 0.8×	229 1.0×	40	1.0k
Laurent Bali France	10	756 0.8×	379 0.8×	90 0.2×	111 0.5×	246 1.1×	17	808

Countries citing papers authored by Ying G. Li

Since Specialization

Citations

This map shows the geographic impact of Ying G. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying G. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying G. Li more than expected).

Fields of papers citing papers by Ying G. Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying G. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying G. Li. The network helps show where Ying G. Li may publish in the future.

Co-authorship network of co-authors of Ying G. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ying G. Li. A scholar is included among the top collaborators of Ying G. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying G. Li. Ying G. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frías, Juan P., Enzo Bonora, Luis Nevárez Ruiz, et al.. (2021). Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11). Diabetes Care. 44(3). 765–773. 123 indexed citations

Frías, Juan P., Alan Wynne, Beata Matyjaszek‐Matuszek, et al.. (2019). Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo‐controlled trial in patients with type 2 diabetes using metformin. Diabetes Obesity and Metabolism. 21(9). 2048–2057. 35 indexed citations

Arakaki, Richard F., et al.. (2015). Two Treatment Approaches for Human Regular U-500 Insulin in Patients With Type 2 Diabetes not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Titration-To-Target Clinical Trial. Endocrine Practice. 21(7). 782–794. 38 indexed citations

Mari, Andrea, Julio Rosenstock, Xiaosu Ma, Ying G. Li, & Jeffrey A. Jackson. (2015). Optimized Human Regular U-500 Insulin Treatment Improves β-Cell Function in Severely Insulin-Resistant Patients with Long-Standing Type 2 Diabetes and High Insulin Requirements. Endocrine Practice. 21(12). 1344–1353. 8 indexed citations

Riesmeyer, Jeffrey S., Daniel E. Salazar, Govinda J. Weerakkody, et al.. (2011). Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON‐TIMI 38 Substudy. The Journal of Clinical Pharmacology. 52(6). 789–797. 41 indexed citations

Zhu, Baojin, Mark B. Effron, Pandurang M. Kulkarni, et al.. (2011). The Onset of Inhibition of Platelet Aggregation With Prasugrel Compared With Clopidogrel Loading Doses Using Gatekeeping Analysis of Integrated Clinical Pharmacology Data. Journal of Cardiovascular Pharmacology. 57(3). 317–324. 16 indexed citations

Jakubowski, Joseph A., Ying G. Li, David S. Small, et al.. (2010). A Comparison of the VerifyNow P2Y12 Point-of-Care Device and Light Transmission Aggregometry to Monitor Platelet Function with Prasugrel and Clopidogrel: An Integrated Analysis. Journal of Cardiovascular Pharmacology. 56(1). 29–37. 39 indexed citations

Small, David S., Christopher D. Payne, Prajakti A. Kothare, et al.. (2010). Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy chinese and white volunteers: An open-label trial. Clinical Therapeutics. 32(2). 365–379. 39 indexed citations

Small, David S., Ying G. Li, C. Steven Ernest, et al.. (2010). Integrated Analysis of Pharmacokinetic Data Across Multiple Clinical Pharmacology Studies of Prasugrel, a New Thienopyridine Antiplatelet Agent. The Journal of Clinical Pharmacology. 51(3). 321–332. 29 indexed citations

10.

Small, David S., Prajakti A. Kothare, Eunice Yuen, et al.. (2009). The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects. European Journal of Clinical Pharmacology. 66(2). 127–135. 55 indexed citations

11.

Wrishko, Rebecca E., C. Steven Ernest, David S. Small, et al.. (2009). Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38. The Journal of Clinical Pharmacology. 49(8). 984–998. 66 indexed citations

12.

Small, David S., Rebecca E. Wrishko, C. Steven Ernest, et al.. (2009). Effect of Age on the Pharmacokinetics and Pharmacodynamics of Prasugrel during Multiple Dosing. Drugs & Aging. 26(9). 781–790. 13 indexed citations

13.

Li, Ying G., Lan Ni, John T. Brandt, et al.. (2009). Inhibition of platelet aggregation with prasugrel and clopidogrel: An integrated analysis in 846 subjects. Platelets. 20(5). 316–327. 51 indexed citations

14.

Small, David S., Nagy A. Farid, Christopher D. Payne, et al.. (2008). Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel. The Journal of Clinical Pharmacology. 48(4). 475–484. 245 indexed citations

15.

Payne, Christopher D., Ying G. Li, John T. Brandt, et al.. (2008). The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration. Thrombosis and Haemostasis. 99(2). 409–415. 99 indexed citations

16.

Payne, Christopher D., Ying G. Li, John T. Brandt, et al.. (2008). Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects. Platelets. 19(4). 275–281. 35 indexed citations

17.

Farid, Nagy A., David S. Small, Christopher D. Payne, et al.. (2008). Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(12). 1483–1493. 73 indexed citations

18.

Small, David S., Nagy A. Farid, Ying G. Li, et al.. (2008). Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. Current Medical Research and Opinion. 24(8). 2251–2257. 47 indexed citations

19.

Payne, Christopher D., Ying G. Li, Nagy A. Farid, et al.. (2007). A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry. Thrombosis and Haemostasis. 99(1). 215–222. 66 indexed citations

20.

Jakubowski, Joseph A., Christopher D. Payne, Govinda Weerakkody, et al.. (2007). Dose-Dependent Inhibition of Human Platelet Aggregation by Prasugrel and its Interaction With Aspirin in Healthy Subjects. Journal of Cardiovascular Pharmacology. 49(3). 167–173. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact